Harvard, 10x accuse NanoString of infringing gene sequencing tech

Harvard College and 10x Genomics have sued Nanostring Technologies, alleging that the company’s CosMx imaging platform infringes two patents covering “gene-mapping” technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

More on this story

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

More on this story

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

More features

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent

‘We took Ravgen head-on’: How we won zero-damages and others didn't

Bristol Myers Squibb leader named INTA 2025 president

Kathi Vidal to leave USPTO ahead of incoming Trump administration

Herbert Smith Freehills and Kramer Levin in $2bn merger talks

Harvard, 10x accuse NanoString of infringing gene sequencing tech

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features